Interaction Checker

Add peptides or compounds to check all pairwise interactions, cumulative organ load, and safety flags.

This stack requires monitoring: 0 interaction(s) need attention. No critical conflicts, but bloodwork and regular check-ins recommended.

Cumulative Organ Load

Gonads
moderate
Heart
moderate
Liver
moderate
Blood Vessels
low

Shared Safety Flags

2x 2 hepatotoxic compounds (Oxandrolone, Pitavastatin). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds disrupt lipids (Oxandrolone, Pitavastatin). Get lipid panel mid-cycle — consider adding lipid support.
2x 2 compounds share the teratogenic safety flag (Oxandrolone, Pitavastatin). Monitor accordingly.
+
Oxandrolone + Pitavastatin
Compatible

Pitavastatin can be safely co-administered with oxandrolone without interaction concerns. Oxandrolone severely impacts lipid profiles, suppressing HDL by 40-50% and elevating LDL. Pitavastatin addresses the LDL component effectively and may provide slightly better HDL support than other statins, though the HDL suppression from oxandrolone will still be substantial. The absence of CYP3A4 involvement means no metabolic competition between the two compounds.

Researched 90% confidence Compare

Interaction data is compiled from research literature, pharmacological analysis, and community reports. Inferred interactions are based on known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.